The "Capping Prescription Costs Act of 2025" caps annual out-of-pocket prescription drug costs at $2,000 for individuals and $4,000 for families, starting in 2026.
Steven Horsford
Representative
NV-4
The "Capping Prescription Costs Act of 2025" caps annual out-of-pocket prescription drug costs for individuals at $2,000 and families at $4,000 starting in 2026. These limits will be adjusted annually based on the consumer price index for medical care. This cap applies to all group health plans and health insurance issuers.
The Capping Prescription Costs Act of 2025 introduces a straightforward limit on how much people have to pay out-of-pocket for prescription drugs each year. Starting in 2026, the proposal sets an annual cap at $2,000 for an individual and $4,000 for a family. This applies to most health insurance plans, including those offered by employers and purchased individually. After the first year, these caps would adjust based on increases in medical care prices.
So, what does this actually mean? If this passes, starting in 2026, once your spending on prescriptions covered by your plan hits $2,000 (or $4,000 for your family total) within a year, you wouldn't pay any more out-of-pocket for covered prescriptions for the rest of that year. Think about someone managing a chronic condition like diabetes or rheumatoid arthritis – their often high and recurring medication costs could hit this ceiling, providing significant financial relief and predictability for the remainder of the year. This cap applies specifically to your out-of-pocket costs, like co-pays and co-insurance, for drugs included in your plan's formulary.
The proposed cap isn't just for specific niche plans; it's designed to apply broadly across the health insurance landscape. Section 2 specifies it covers group health plans (like the insurance many get through work) and individual health insurance policies regulated under the Affordable Care Act. The bill also includes a mechanism for the future: after 2026, the $2,000 and $4,000 limits aren't fixed forever. They'll be adjusted annually based on the Consumer Price Index for medical care (CPI-MC), rounded down to the nearest $5. This means the caps will likely rise slowly over time, intended to keep pace with general medical inflation.
The core idea here is financial protection. Unexpected health issues or ongoing conditions requiring expensive medications can lead to huge, unpredictable bills. This legislation aims to put a firm upper limit on that specific part of healthcare spending – your share of prescription drug costs. It doesn't change the sticker price of drugs charged by manufacturers, nor does it dictate which drugs insurance must cover. Instead, it focuses squarely on limiting the maximum financial exposure for individuals and families when it comes to paying for the medications their plan does cover.